61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Fisher & Paykel Healthcare Corp Ltd
Closed
Sector Real estate
35.15 0.63
Overview
Share price change
24h
Min
34.72
Max
35.25
Income | 141M 153M |
|---|---|
Sales | 482M 951M |
P/E Sector Avg | 126.745 83.663 |
EPS | 0.26 |
Dividend yield | 1.519 |
Profit margin | 16.106 |
Employees | 7,141 |
EBITDA | 6.4M 276M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +10.31 upside |
Dividend yield Sector Avg | 1.52% 4.49% |
|---|
Market Cap | -289M 20B |
|---|---|
Previous open | 34.52 |
Previous close | 35.15 |
News Sentiment
By Acuity
50%
50%
64 / 193 Real estate
Fisher & Paykel Healthcare Corp Ltd Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Fisher & Paykel Healthcare Corp Ltd Forecast
Price Target
By TipRanks
10.31% upside
12 Months Forecast
Average 38.51 AUD 10.31%
High 42.7 AUD
Low 34.7 AUD
Based on 6 Wall Street analysts offering 12 month price targets forFisher & Paykel Healthcare Corp Ltd - Dist in the last 3 months.
Sentiment
By Acuity
64 / 193 Real estate
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Fisher & Paykel Healthcare Corp Ltd
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.
